genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Anticancer Immune Cells Identified Using Antigen Receptor Barcode Tracker
News
Firm Up that Skin with Loose RNA
News
Anorexia Partly a Metabolic Disorder, Suggests Genomic Study
News
27-Year-Old Suspect Charged in Murder of Max Planck Institute Scientist
News
Removing Anthrax Bacterial Armor May Lead to New Therapies
Insights
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
Tech Exclusives
An Integrated Digital Vision for Biomanufacturing’s Future
Tech Exclusives
CRISPR and LASER ART Eliminate HIV from Mice
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Anticancer Immune Cells Identified Using Antigen Receptor Barcode Tracker
News
Firm Up that Skin with Loose RNA
News
Anorexia Partly a Metabolic Disorder, Suggests Genomic Study
News
Removing Anthrax Bacterial Armor May Lead to New Therapies
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
July 2019 Vol. 39 No. 7
Advanced Mass Spectrometry Drives Translational Cancer Biomarker Research beyond Discovery
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Cervical Cancer
Cervical Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cervical Cancer
Cervical Microbiome May Promote Cancer
Cervical Cancer
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination
Cervical Cancer
FDA Approves Cervical-Cancer-Related HPV Test
Cervical Cancer
BMS, Advaxis, Array Ink Independent Deals to Evaluate Combo Cancer Therapies
Cervical Cancer
Genticel to Shrink Workforce 30%
Cervical Cancer
New Biomarker Is Predictor of Metastatic Cancer
Cervical Cancer
FDA Places Advaxis Cancer Immunotherapy on Clinical Hold
Cervical Cancer
MedImmune Licenses Inovio Cancer Vaccine for Up-to $727.5M
Cervical Cancer
Kite Pharma, bluebird bio Partner on Cancer Immunotherapies
Cervical Cancer
Selecta Receives $3.2M from Skolkovo Foundation for Immuno-oncology Program
Cervical Cancer
Avastin Wins FDA Nod for Advanced Forms of Cervical Cancer
Cervical Cancer
Biocon, Advaxis Ink Deal for HPV-Associated Cervical Cancer Compound
Cervical Cancer
Advaxis, Global BioPharma Ink Licensing Agreement for HPV Candidate
Cervical Cancer
Positive Phase III Results for Merck & Co.’s HPV Vaccine Candidate
Cervical Cancer
CEL-SCI, Ergomed to Co-Develop Head and Neck Cancer Candidate as Potential...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
